108 related articles for article (PubMed ID: 21611039)
1. Dual time point imaging of FDG PET/CT in a tuberculous spondylodiscitis.
Abdul H; Abdul N; Nordin A
Biomed Imaging Interv J; 2010; 6(2):e18. PubMed ID: 21611039
[TBL] [Abstract][Full Text] [Related]
2. Dual-time point
Parghane RV; Basu S
Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of F-18 FDG PET/CT in patients with spondylodiscitis: Is dual time point imaging time worthy?
Gunes BY; Onsel C; Sonmezoglu K; Ozaras R; Halac M; Tabak F; Sager S; Mete B; Sayman H; Kanmaz B
Diagn Microbiol Infect Dis; 2016 Jul; 85(3):381-385. PubMed ID: 27160950
[TBL] [Abstract][Full Text] [Related]
4. Imaging characteristics of extrapulmonary tuberculosis lesions on dual time point imaging (DTPI) of FDG PET/CT.
Razak HR; Geso M; Abdul Rahim N; Nordin AJ
J Med Imaging Radiat Oncol; 2011 Dec; 55(6):556-62. PubMed ID: 22141602
[TBL] [Abstract][Full Text] [Related]
5. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Metabolic changes in breast cancer on dual-time-point
Kim HO; Kim BS; Kang SY; Bang JI; An J; Kim JH; Yoon HJ
Ann Nucl Med; 2020 Dec; 34(12):942-951. PubMed ID: 32974848
[TBL] [Abstract][Full Text] [Related]
8. Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis.
Bassetti M; Merelli M; Di Gregorio F; Della Siega P; Screm M; Scarparo C; Righi E
Skeletal Radiol; 2017 Jun; 46(6):777-783. PubMed ID: 28299432
[TBL] [Abstract][Full Text] [Related]
9. Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
Chen S; Li X; Chen M; Yin Y; Li N; Li Y
Eur J Radiol; 2016 Oct; 85(10):1744-1749. PubMed ID: 27666611
[TBL] [Abstract][Full Text] [Related]
10. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?
Cheng G; Torigian DA; Zhuang H; Alavi A
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):779-87. PubMed ID: 23361859
[TBL] [Abstract][Full Text] [Related]
11. Dual time point fluorodeoxyglucose positron emission tomography/computed tomography in differentiation between malignant and benign lesions in cancer patients. Does it always work?
Saleh Farghaly HR; Mohamed Sayed MH; Nasr HA; Abdelaziz Maklad AM
Indian J Nucl Med; 2015; 30(4):314-9. PubMed ID: 26430314
[TBL] [Abstract][Full Text] [Related]
12. Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.
Nakayama M; Okizaki A; Ishitoya S; Sakaguchi M; Sato J; Aburano T
Ann Nucl Med; 2013 Feb; 27(2):163-9. PubMed ID: 23188388
[TBL] [Abstract][Full Text] [Related]
13. Does dual-time-point
Wu B; Zhao Y; Zhang Y; Tan H; Shi H
Hell J Nucl Med; 2017; 20(1):79-82. PubMed ID: 28315913
[TBL] [Abstract][Full Text] [Related]
14. Experience of Dual Time Point Brain F-18 FDG PET/CT Imaging in Patients with Infectious Disease.
Kim DW; Kim CG; Park SA; Jung SA
Nucl Med Mol Imaging; 2010 Jun; 44(2):137-42. PubMed ID: 25013525
[TBL] [Abstract][Full Text] [Related]
15. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR
Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
[TBL] [Abstract][Full Text] [Related]
16. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
Purandare NC; Pramesh CS; Agarwal JP; Agrawal A; Shah S; Prabhash K; Karimundackal G; Jiwnani S; Tandon S; Rangarajan V
Indian J Cancer; 2017; 54(1):271-275. PubMed ID: 29199704
[TBL] [Abstract][Full Text] [Related]
17. Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
Dancheva Z; Bochev P; Chaushev B; Yordanova T; Klisarova A
Nucl Med Rev Cent East Eur; 2016; 19(1):22-7. PubMed ID: 26841376
[TBL] [Abstract][Full Text] [Related]
18. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.
Esen Akkas B; Gökaslan D; Güner L; Ilgin Karabacak N
Rev Esp Med Nucl; 2011; 30(1):14-8. PubMed ID: 20702004
[TBL] [Abstract][Full Text] [Related]
19. Dual-time-point
Huang YE; Huang YJ; Ko M; Hsu CC; Chen CF
Ann Nucl Med; 2016 Nov; 30(9):652-658. PubMed ID: 27492555
[TBL] [Abstract][Full Text] [Related]
20. (18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients.
Iagaru A; Mosci C; Shen B; Chin FT; Mittra E; Telli ML; Gambhir SS
Radiology; 2014 Nov; 273(2):549-59. PubMed ID: 25033190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
